Handling and Assessment of Human Primary Prostate Organoid Culture
January 17th, 2019
Here, we present a protocol to guide human primary prostate organoid handling then suggest endpoints to assess phenotype. Seeding, culture maintenance, recovery from matrix gel, morphologic quantification, embedding and sectioning, FFPE sectioning, whole-mount staining, and application of commercial assays are described.
Overview
This protocol outlines the handling of human primary prostate organoids, detailing methods for seeding, culture maintenance, and phenotypic assessment. It provides a comprehensive guide for new users to navigate the complexities of organoid culture and analysis.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Oncology
Background
- Prostate organoids serve as a valuable in vitro model for studying prostate development and disease.
- They provide an alternative to traditional cell lines and animal models.
- Organoids can be derived from both human and mouse prostate cells.
- Precision medicine approaches can utilize patient-derived organoids for therapeutic response modeling.
Purpose of Study
- To consolidate various culture methods and endpoints for prostate organoids.
- To guide researchers through the challenging steps of organoid handling.
- To enhance the reproducibility and reliability of organoid-based experiments.
Methods Used
- Seeding epithelial cells in matrix gel-coated plates.
- Recovery of organoids using neutral protease treatment.
- Embedding organoids in histology gel for sectioning.
- Staining and imaging organoid sections for phenotypic analysis.
Main Results
- Successful culture and recovery of human primary prostate organoids.
- Demonstration of effective embedding and sectioning techniques.
- Visualization of organoid morphology through various staining methods.
- Identification of key phenotypic markers in organoid sections.
Conclusions
- The protocol provides a reliable framework for prostate organoid research.
- It facilitates the study of prostate cancer and therapeutic responses.
- Future adaptations of the protocol may benefit other tissue types.
Frequently Asked Questions
Executive Industry Relevance
Human primary prostate organoids provide a physiologically relevant in vitro system for modeling prostate biology and disease, reducing reliance on immortalized cell lines and animal models. This protocol enables standardized culture, handling, and phenotypic assessment, supporting target validation and preclinical de-risking in oncology drug discovery. The approach facilitates mechanistic studies and therapeutic response modeling using patient-derived samples, enhancing translational continuity in prostate cancer research pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses in a disease-relevant human tissue model.
- Operational Value: Supports functional target validation through phenotypic readouts like morphology and marker expression.
- Predictive Value: Improves confidence in target modulation by capturing organoid-level responses.
Screening & Assay Development
- Assay Readiness: Generates standardized 3D cultures suitable for compound screening in 96-well format.
- Quantitative Outputs: Enables measurement of organoid area, circularity, and roundness from z-stack imaging for high-content analysis.
- Assay Adaptability: Allows modification of commercial 2D assays for 3D organoid use, expanding screening compatibility.
Translational & Preclinical Research
- Disease Modeling: Supports patient-derived organoid cultures for precision medicine approaches.
- Translational Biomarker Alignment: Enables correlation of in vitro marker expression (e.g., cytokeratin 5/8, p63) with in vivo phenotypes.
- Preclinical Continuity: Provides a bridge from discovery to preclinical validation via histology, immunostaining, and molecular analysis.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through lead identification to preclinical evaluation, particularly for prostate cancer therapeutics.
- Discovery Biology: Supports hypothesis testing and pathway clarification using primary human prostate epithelial cells in 3D culture.
- Screening: Delivers reproducible, quantifiable organoid phenotypes for reliable compound screening campaigns.
- Analytics: Provides morphometric and molecular readouts (area, circularity, marker expression) to compare experimental conditions.
- Translational Research: Connects discovery to preclinical validation through FFPE sectioning, immunostaining, and organoid recovery for downstream assays.
- Enterprise Reuse: Establishes a scalable, standardized platform for prostate organoid culture applicable across multiple projects and indications.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence by reducing mechanistic ambiguity in prostate cancer models.
- Operational Value: Delivers standardized, reproducible organoid culture and assessment across laboratories.
- Strategic Value: Improves go/no-go decisions by providing human-relevant efficacy and toxicity data early in discovery.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds based on organoid response profiles.
Implementation Considerations
- Requires expertise in 3D cell culture, histology, and microscopy techniques.
- Dependent on specialized equipment including centrifuges, incubators, microtomes, and confocal imagers.
- Necessitates standardized training for consistent organoid handling, embedding, and staining.
- Involves optimization considerations when adapting to different cell types or genetic backgrounds.
- Limited by organoid variability and the need for careful validation of assay compatibility in 3D format.
Biopharma FAQs
Chapters in this video
0:04
Title
1:04
Collection of Organoids from Matrix Gel
2:09
Formalin Fixation and Paraffin Embedding of Organoids for Histological Endpoints
4:00
Sectioning the Formalin Fixed Paraffin Embedded (FFPE) Histology Gel Blocks
5:04
Whole-mounting of Organoids for Immunofluorescent Staining
6:35
Results: Analysis of Human Primary Prostate Organoids
7:56
Conclusion
